What is the translation of " RELEVANT DIFFERENCES " in Swedish?

• relevanta skillnader
• relevant skillnad

Examples of using Relevant differences in English and their translations into Swedish

No relevant differences in pharmacokinetics have been observed.
Inga relevanta skillnader i farmakokinetiken har observerats.

On the contrary, the exercise of judgement is required to distinguish relevant differences from irrelevant ones.
Det krävs tvärtom omdöme för att kunna skilja relevanta olikheter från irrelevanta.

There were no clinically relevant differences in Cmax compared to healthy volunteers.
Det finns ingen kliniskt relevant skillnad i Cmax jämfört med friska frivilliga.

whether they are morally relevant differences.
utan ifall det är moraliskt relevanta skillnader.

There seem to be relevant differences between pediatric and adult SCIWORA.
Det finns en väsentlig skillnad mellan figuriner från gravettien- respektive magdalenienkulturerna.

In healthy female and male subjects following single and multiple-doses of tadalafil, no clinically relevant differences in exposure were observed.
Det har inte observerats några kliniskt relevanta skillnader exponeringen på friska frivilliga kvinnor och män som fått engångsdos respektive flera doser av tadalafil.

There are no clinically relevant differences in the pharmacokinetics of brivaracetam by gender.
Det finns inga kliniskt relevanta skillnader i farmakokinetiken för brivaracetam beroende på kön.

A population PK analysis did not identify clinically relevant differences in PK of cabozantinib based on race.
Vid en farmakokinetisk populationsanalys identifierades inga kliniskt relevanta skillnader i PK för cabozantinib baserat på etnicitet.

No clinically relevant differences in the pharmacokinetics of rilpivirine have been observed between men and women.
Inga kliniskt relevanta skillnader i farmakokinetiken för rilpivirin har iakttagits mellan män och kvinnor.

The results demonstrated no clinically relevant differences between sildenafil and placebo in time to limiting angina.
Resultatet visade ingen klinisk relevant skillnad mellan sildenafil och placebo i tid för att lindra angina.

No clinically relevant differences in adverse reactions were observed between the overall dataset and the approved indications.
Inga kliniskt relevanta skillnader i biverkningar observerades mellan det totala datasetet och den godkända indikationen.

Dapagliflozin: There were no clinically relevant differences in systemic exposures between White,
Dapagliflozin: Det fanns inga kliniskt relevanta skillnader i systemisk exponering mellan vita,

There were no clinically relevant differences in incidence or severity of hypoglycaemia with exenatide compared to placebo,
Man såg ingen kliniskt relevant skillnad i incidens eller hypoglykemins allvarlighetsgrad för exenatid jämfört med placebo,

There were no clinically relevant differences in the clearance of tigecycline between men and women.
Det förelåg inga kliniskt relevanta skillnader i clearance för tigecyklin mellan män och kvinnor.

No clinical relevant differences were demonstrated in time to limiting angina for sildenafil when compared with placebo in a double blind,
Ingen klinisk relevant skillnad visades vad gäller tid till symtomgivande angina då sildenafil jämfördes med placebo i en dubbel-blind,

There were no clinically relevant differences observed in saxagliptin pharmacokinetics between males and females.
Det observerades inga kliniskt relevanta skillnader i saxagliptins farmakokinetik mellan män och kvinnor.

There were no clinically relevant differences in safety between males(N=382)
Det fanns inga kliniskt relevanta skillnader i säkerhet mellan män(n=382)

There are no clinically relevant differences between genders in pharmacokinetic properties of insulin detemir.
Det föreligger inga kliniskt relevanta skillnader mellan könen vad gäller de farmakokinetiska egenskaperna för insulin detemir.

There were no clinically relevant differences in pharmacokinetics and pharmacodynamics between male
Det fanns inga kliniskt relevanta skillnader i farmakokinetik och farmakodynamik mellan manliga

There were no clinically relevant differences observed for the safety profile of pemetrexed within the histology subgroups.
Inga kliniskt relevanta skillnader observerades i säkerhetsprofilen för pemetrexed inom de histologiska undergrupperna.

There were no clinically relevant differences observed for the safety profile of ALIMTA within the histology subgroups.
Inga kliniskt relevanta skillnader beträffande säkerhetsprofilen av ALIMTA observerades inom de histologiska undergrupperna.

In clinical studies, no relevant differences in exposure or efficacy were observed between patients of different ethnic groups.
I kliniska studier observerades inga relevanta skillnader i exponering och effekt mellan patienter från olika etniska grupper.

In clinical studies, no relevant differences in exposure, safety
I kliniska studier observerades inga relevanta skillnader i exponering, säkerhet

There were no clinically relevant differences in empagliflozin pharmacokinetics between healthy volunteers
Det fanns inga kliniskt relevanta skillnader i empagliflozinets farmakokinetik mellan friska frivilliga

There were no clinically relevant differences observed for the safety profile of ALIMTA plus cisplatin within the histology subgroups.
Det observerades inga kliniskt relevanta skillnader med avseende på säkerhetsprofilen för ALIMTA plus cisplatin inom de histologiska undergrupperna.

Although they could lead to substantial benefits by effectively removing all the relevant differences between national laws
Även om de skulle kunna leda till påtagliga fördelar genom att effektivt avlägsna alla viktiga skillnader mellan nationella lagar

There were neither statistically significant nor clinically relevant differences in bevacizumab clearance in patients receiving Avastin monotherapy compared to patients receiving Avastin in combination with interferon alfa-2a, erlotinib
Ingen statistiskt signifikant eller kliniskt relevant skillnad i clearance av bevacizumab observerades vid jämförelse av patienter som behandlades med Avastin som enda läkemedel och patienter som fick Avastin i kombination med interferon alfa-2a,